Immunovant’s Post

View organization page for Immunovant, graphic

14,185 followers

Graves’ disease is a common autoimmune condition in which the body overproduces thyroid hormones causing #hyperthyroidism. Learn more about the symptoms, challenges in disease management and Immunovant’s patient-focused approach to help advance treatments for Graves' disease: https://lnkd.in/gmqubMmH #GravesDisease #endocrinology #thyroid #InvisibleDisability #AutoImmuneDisease #autoimmune #PatientFirst #healthcare

Barbara Fersch

Associate Professor hos University of Southern Denmark

1mo

This sounds promising! How long is this potential treatment away from approval? As a Graves and TED patient, in remission after the first relapse of both, thyroidectomy is probably very much on the table, when (not if, I guess ☹) the next relapse comes... But if new effective treatment is on the way it might potentially make sense to wait it out as long as possible?

Bilal Bham

I am a registered Diverse Supplier helping biotech, pharma, and medical devices companies bring their products to market and patients through regulatory submissions and medical communications.

2mo

I am a Graves and TED patient, and pharma professional. I would love to help if I can 🙌🏾

Karen O.

Senior Director @ X4 Pharmaceuticals | Patient Affairs and Advocacy

2mo

Very hopeful for this as I am a Graves and TED patient as well.

See more comments

To view or add a comment, sign in

Explore topics